Company profile for Eurofins Discovery

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Eurofins Discovery has supported Drug Discovery research for over 40 years. We are recognized as the industry leader for providing drug discovery researchers the largest and most diverse portfolio of standard and custom in vitro safety & pharmacology assays and panels for drug screening and profiling. In addition to our in vitro safety pharmacology strengths, we also offer a broad portfolio of over 3500 drug discovery services...
Eurofins Discovery has supported Drug Discovery research for over 40 years. We are recognized as the industry leader for providing drug discovery researchers the largest and most diverse portfolio of standard and custom in vitro safety & pharmacology assays and panels for drug screening and profiling. In addition to our in vitro safety pharmacology strengths, we also offer a broad portfolio of over 3500 drug discovery services and 1800 products. These include medicinal & synthetic chemistry, in vitro pharmacology, safety pharmacology & efficacy, ADME-Tox, cell-based phenotypic assays, & custom proteins & assay development capabilities.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
15 Research Park Drive St Charles, MO 63304
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/complete-genomics-adds-eurofins-clinical-enterprise-llc-to-its-sequencing-service-provider-program-302333092.html

PR NEWSWIRE
17 Dec 2024

https://www.businesswire.com/news/home/20241010180689/en

BUSINESSWIRE
10 Oct 2024

https://www.reuters.com/business/eurofins-denies-short-seller-allegations-after-share-slump-2024-06-25//

REUTERS
25 Jun 2024

https://www.prnewswire.com/news-releases/eurofins-discovery-collaborating-with-invasight-on-cancer-therapies-301744646.html

PR NEWSWIRE
15 Feb 2023

https://www.prnewswire.com/news-releases/eurofins-discovery-announces-acquisition-of-discoverybiomed-301580619.html

PRNEWSWIRE
05 Jul 2022
Eurofins DiscoverX Certifies KBI Biopharma
Eurofins DiscoverX Certifies KBI Biopharma

11 Oct 2021

// CONTRACTPHARMA

https://www.contractpharma.com/contents/view_breaking-news/2021-10-11/eurofins-discoverx-certifies-kbi-biopharma/?widget=listSection

CONTRACTPHARMA
11 Oct 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty